EssilorLuxottica Société anonyme against Teva Pharmaceutical Industries Limited — live side-by-side technical comparison.
Prices as of 2026-10-13T15:36:08+00:00 UTC · updates daily
TEVA leads 5 of the 5 windows we measure — over 1 month EL.PA is -0.1% and TEVA +11.2%; over year to date EL.PA is -45.8% and TEVA +32.2%.
| EL.PA | TEVA | |
|---|---|---|
| Price | $146.30 | $41.25 |
| 1 day | -0.3% | +0.2%lead |
| 5 days | -0.3% | +5.4%lead |
| 1 month | -0.1% | +11.2%lead |
| 6 months | -25.8% | +32.4%lead |
| Year to date | -45.8% | +32.2%lead |
| 52-week position | 4% of range | 97% of range |
| 52-week range | $138.30–$323.80 | $18.83–$42.02 |
| vs 50-day average | below $153.32 | above $37.88 |
| vs 200-day average | below $190.72 | above $34.01 |
| RSI (14) | 43 | 66 |
| Next earnings | 2026-02-11 | 2026-11-03 |
EL.PA trades at $146.30, below its 50-day average of $153.32, and below the 200-day at $190.72. It sits at 4% of its 52-week range ($138.30–$323.80); 14-day RSI is 43, in neutral territory; an average session moves it about 2.8%. For levels, the first level overhead is $150.00 (2.5% away) and the first support below is $139.00 (5.0% down). On the checklist the page runs for every asset, 1 of 6 checks read bullish — the lean is bearish.
TEVA trades at $41.25, above its 50-day average of $37.88, and above the 200-day at $34.01. It sits at 97% of its 52-week range ($18.83–$42.02); 14-day RSI is 66, in neutral territory; an average session moves it about 2.9%. For levels, the first level overhead is $45.00 (9.1% away) and the first support below is $40.00 (3.0% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
Both move about the same amount day to day (2.8% and 2.9% of price), so the same position size carries comparable risk in either.
The comparison turns on those levels: EL.PA clearing $150.00 or losing $139.00; TEVA clearing $45.00 or losing $40.00. Until one of them gives way, the relative reading above stands.